418 related articles for article (PubMed ID: 17021752)
1. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
Huse JT; Pasha TL; Zhang PJ
Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical distinction of classic and chondroid chordomas.
Walker WP; Landas SK; Bromley CM; Sturm MT
Mod Pathol; 1991 Sep; 4(5):661-6. PubMed ID: 1722044
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and ultrastructural study of skull base chordomas.
Kubota T; Sato K; Kabuto M; Kawano H; Nakagawa T; Arai Y; Tachibana O; Yoshida K; Yamashita J
Noshuyo Byori; 1994; 11(1):23-8. PubMed ID: 7512866
[TBL] [Abstract][Full Text] [Related]
6. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
7. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
Daugaard S; Christensen LH; Høgdall E
APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
[TBL] [Abstract][Full Text] [Related]
8. Chondroid chordoma of the sacrococcygeal region.
Chu TA
Arch Pathol Lab Med; 1987 Sep; 111(9):861-4. PubMed ID: 2443106
[TBL] [Abstract][Full Text] [Related]
9. Chordoma. An immunohistochemical study of 20 cases.
Meis JM; Giraldo AA
Arch Pathol Lab Med; 1988 May; 112(5):553-6. PubMed ID: 2451900
[TBL] [Abstract][Full Text] [Related]
10. A reassessment of "chordoid sarcoma". Ultrastructural and immunohistochemical comparison with chordoma and skeletal myxoid chondrosarcoma.
Wick MR; Burgess JH; Manivel JC
Mod Pathol; 1988 Nov; 1(6):433-43. PubMed ID: 2464825
[TBL] [Abstract][Full Text] [Related]
11. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
12. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
Rosenberg AE; Brown GA; Bhan AK; Lee JM
Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
14. Chondroid chordoma. A hyalinized chordoma without cartilaginous differentiation.
Jeffrey PB; Biava CG; Davis RL
Am J Clin Pathol; 1995 Mar; 103(3):271-9. PubMed ID: 7532910
[TBL] [Abstract][Full Text] [Related]
15. [Pathology of myxoid bone tumors of the skull base].
Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
[TBL] [Abstract][Full Text] [Related]
16. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
17. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
[TBL] [Abstract][Full Text] [Related]
18. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.
Hruban RH; Traganos F; Reuter VE; Huvos AG
Am J Pathol; 1990 Aug; 137(2):435-47. PubMed ID: 1696786
[TBL] [Abstract][Full Text] [Related]
19. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
20. Chondrosarcoma is not characterized by detectable telomerase activity.
Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
